Zydus Lifesciences informs about press release

27 Nov 2025 Evaluate

Zydus Lifesciences has informed that it enclosed press release titled ‘Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg.’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

895.15 -17.80 (-1.95%)
09-Mar-2026 11:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.70
Dr. Reddys Lab 1287.10
Cipla 1313.60
Zydus Lifesciences 895.15
Lupin 2308.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×